Trial Profile
A Clinical Pharmacological Study to Assess Pharmacodynamic and Pharmacokinetic Interactions Between Furosemide and Ipragliflozin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jun 2014
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary) ; Furosemide
- Indications Heart failure; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Astellas Pharma Europe Ltd
- 12 Jun 2012 New trial record